ロード中...
Efficacy of Ravuconazole in Treatment of Systemic Murine Histoplasmosis
Ravuconazole (RCZ) was evaluated for efficacy in comparison to fluconazole (FCZ) and itraconazole (ITZ) in murine models of disseminated histoplasmosis. All regimens tested prolonged survival (P < 0.05 to 0.0001). At equivalent doses of 50 mg/kg of body weight, RCZ and ITZ were equally effective...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC127511/ https://ncbi.nlm.nih.gov/pubmed/11850289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.3.922-924.2002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|